Leef Brands, Inc. (LEEF.CX)
0.22
0.00 (0.00%)
CAD |
CNSX |
Jun 10, 15:59
Leef Brands Shareholders Equity (Quarterly) : -8.024M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -8.024M |
| December 31, 2025 | -11.33M |
| September 30, 2025 | -22.57M |
| June 30, 2025 | -17.85M |
| March 31, 2025 | -12.82M |
| September 30, 2024 | -0.6252M |
| June 30, 2024 | 1.013M |
| March 31, 2024 | -7.461M |
| December 31, 2023 | -6.450M |
| September 30, 2023 | 5.953M |
| June 30, 2023 | 9.770M |
| March 31, 2023 | 36.62M |
| December 31, 2022 | 32.44M |
| September 30, 2022 | 55.37M |
| January 31, 2022 | 45.78M |
| October 31, 2021 | 46.16M |
| July 31, 2021 | 46.16M |
| April 30, 2021 | 66.78M |
| Date | Value |
|---|---|
| January 31, 2021 | 66.28M |
| October 31, 2020 | 66.05M |
| July 31, 2020 | 49.32M |
| April 30, 2020 | 65.64M |
| January 31, 2020 | 52.49M |
| October 31, 2019 | 53.04M |
| July 31, 2019 | |
| April 30, 2019 | 1.353M |
| January 31, 2019 | 1.458M |
| October 31, 2018 | 1.826M |
| July 31, 2018 | 2.009M |
| April 30, 2018 | 3.697M |
| January 31, 2018 | 3.758M |
| October 31, 2017 | 3.603M |
| July 31, 2017 | 0.7518M |
| April 30, 2017 | -0.8864M |
| January 31, 2017 | -0.8439M |
| October 31, 2016 | -0.8393M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| NeutriSci International, Inc. | -- |
| Jamieson Wellness, Inc. | 492.41M |
| Vitality Products, Inc. | -1.520M |
| Genix Pharmaceuticals Corp. | -1.471M |
| LSL Pharma Group, Inc. | 24.17M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 58.40M |
| Total Liabilities (Quarterly) | 66.43M |
| Debt to Equity Ratio | -2.141 |
| Current Ratio | 1.75 |
| Net Debt Paydown Yield | 4.75% |